Abbott Narrows 2026 Adjusted Diluted EPS Guidance to $5.50-$5.55

Bitget2026/10/21 12:10

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Abbott tightened its full-year 2026 adjusted diluted EPS guidance to $5.50-$5.55, reaffirming the midpoint.
Full-year comparable sales growth is expected at approximately 6%.
Third-quarter worldwide sales reached $13 billion, up 7% on a comparable basis.
Adjusted diluted EPS rose 9.2% to $1.42 in the quarter.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abbott Laboratories published the original content used to generate this news brief on October 20, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Abbott Narrows 2026 Adjusted Diluted EPS Guidance to $5.50-$5.55

You may also like

Crypto prices